1
outcomes. Multiple linear regressions were performed to deter- mine relative delayed time ratios (DTRs) as determined by the natural log of delay times for individual variables. The patient group consisted of 894 patients with a median age of 62 years; 294 (32.9%) were female; and 653 (73.3%) were transferred from non-tertiary care facilities. The median time from arrival to diagnosis was 4.3 h, and from diagnosis to surgery was 4.3 h. The greatest relative predictors of delay to diagnosis were transfer from outside facility (DTR 3.34; 95% confidence interval [CI] 2.38–4.69), fever (DTR 5.11; 95% CI 2.07– 12.62), and normotension (DTR 2.45; 95% CI 1.80–3.33). Delays in time to diagnosis also occurred in female patients, patients who had undergone prior cardiac surgery, patients with an electrocardiogram suggestive of myocardial ischemia, or patients with a normal chest radiograph (all p < 0.05). Patients with typical symptoms (defined as posterior pain, abrupt pain, and worst pain ever) were diagnosed twice as quickly as others in the cohort. Critically ill patients with hypotension, tampo- nade, pulse deficits, coma, or altered consciousness were also diagnosed sooner (all p < 0.05). Variables associated with the greatest delay in time to surgery included race other than white (DTR 2.25; 95% CI 0.40–1.22), history of coronary artery bypass surgery (DTR 2.81; 95% CI 0.47–1.60), and time from presentation to diagnosis (DTR 1.35; 95% CI 0.24–0.37). Patients with shock, cardiac tamponade, and diabetes mellitus went to surgery far more rapidly than others in the cohort (all p < 0.05). [Omeed Saghafi, MD Denver Health Medical Center, Denver, CO] Comment: This study validates what the emergency physi- cian would suspect with respect to patients presenting with aortic dissection; when the diagnosis is self evident, delays to therapy are not an issue and when the presentation is atypical, delays become a problem. What was not clear, at least from this study, was whether such delays led to changes in outcomes. Nonetheless, the study findings serve as a reminder that aortic dissection may mimic other pathology and should be considered when appropriate so as to minimize the possibility of delays. , SADDLE PULMONARY EMBOLISM: IS IT AS BAD AS IT LOOKS? A COMMUNITY HOSPITAL EXPERI- ENCE Sardi A, Gluskin K, Guttentag A, et al. Crit Care Med 2011;39:2413–8. The outcomes and clinical presentation for saddle pulmo- nary embolism (SPE) vary widely, and there is debate for the use of thrombolytics or catheter thrombectomy based on right heart dysfunction, measures seen on computed tomography an- giography (CTA) or cardiac enzyme elevation. In this study, two radiologists retrospectively reviewed and evaluated for clot bur- den (CB) all CTAs coded for pulmonary embolism (PE) from all patients at a single center from 2004 to 2009. All patient charts were reviewed for echocardiography, treatments, and outcomes. SPE was found in 37 of 680 patients (5.4%), with a median age of 60 years, of whom 41% were male and 83.7% were African- American. Of the 37, the most common comorbidities were un- derlying neurologic disease, recent surgery, smoking (all 24%), and malignancy (22%). Echocardiography was performed in 27 patients (73%). Right heart enlargement and dysfunction oc- curred in 78%, and elevated pulmonary artery systolic pressure in 67%. The Qanadi scoring system for clot burden and pulmo- nary artery occlusion defines complete proximal obstruction with a CB of 40 points; CTA demonstrated a high median score of 31 points. There were 2 deaths (5.4%), with CBs of 30 and 31, but the small number of deaths made it impossible to determine which characteristics were associated with mortality. The me- dian right-ventricle-to-left-ventricle diameter ratio was 1.39, and in those given thrombolytics it was 1.86 (p = 0.13), and the median CB of those who received thrombolytics was 34, compared to 31. Inferior vena cava filters were placed in 46%. Unfractionated heparin was administered in 87%, low-molecu- lar-weight heparin in 11%, thrombolytics in 11%, and surgical thrombectomy in 3%. Median length of hospital stay was 9 days. Of the 4 patients who received thrombolytics, major bleeds occurred in 2, one of which died of multi-organ failure on hospital day 13. [Douglas Melzer, MD Denver Health Medical Center, Denver, CO] Comments: This small retrospective study demonstrated that the incidence of saddle pulmonary embolism was very low and that when it did occur, it was almost always amenable to stan- dard therapy. This raises the question of when thrombolysis or more invasive thrombectomy is really needed, especially when 1 of the 2 patients receiving the former died in this cohort. It may be that SPE is not as life-threatening an entity as previ- ously believed. However, larger studies would have to be done to verify this. 246 Abstracts

Saddle Pulmonary Embolism: Is It As Bad As It Looks? A Community Hospital Experience: Sardi A, Gluskin K, Guttentag A, et al. Crit Care Med 2011;39:2413–8

Embed Size (px)

Citation preview

Page 1: Saddle Pulmonary Embolism: Is It As Bad As It Looks? A Community Hospital Experience: Sardi A, Gluskin K, Guttentag A, et al. Crit Care Med 2011;39:2413–8

246 Abstracts

outcomes. Multiple linear regressions were performed to deter-mine relative delayed time ratios (DTRs) as determined by thenatural log of delay times for individual variables. The patientgroup consisted of 894 patients with a median age of 62 years;294 (32.9%) were female; and 653 (73.3%) were transferredfrom non-tertiary care facilities. The median time from arrivalto diagnosis was 4.3 h, and from diagnosis to surgery was4.3 h. The greatest relative predictors of delay to diagnosiswere transfer from outside facility (DTR 3.34; 95% confidenceinterval [CI] 2.38–4.69), fever (DTR 5.11; 95% CI 2.07–12.62), and normotension (DTR 2.45; 95% CI 1.80–3.33).Delays in time to diagnosis also occurred in female patients,patients who had undergone prior cardiac surgery, patientswith an electrocardiogram suggestive of myocardial ischemia,or patients with a normal chest radiograph (all p < 0.05). Patientswith typical symptoms (defined as posterior pain, abrupt pain,and worst pain ever) were diagnosed twice as quickly as othersin the cohort. Critically ill patients with hypotension, tampo-nade, pulse deficits, coma, or altered consciousness were alsodiagnosed sooner (all p < 0.05). Variables associated with thegreatest delay in time to surgery included race other than white(DTR 2.25; 95% CI 0.40–1.22), history of coronary arterybypass surgery (DTR 2.81; 95% CI 0.47–1.60), and time frompresentation to diagnosis (DTR 1.35; 95% CI 0.24–0.37).Patients with shock, cardiac tamponade, and diabetes mellituswent to surgery far more rapidly than others in the cohort(all p < 0.05).

[Omeed Saghafi, MD

Denver Health Medical Center, Denver, CO]

Comment: This study validates what the emergency physi-cian would suspect with respect to patients presenting withaortic dissection; when the diagnosis is self evident, delays totherapy are not an issue and when the presentation is atypical,delays become a problem. What was not clear, at least fromthis study, was whether such delays led to changes in outcomes.Nonetheless, the study findings serve as a reminder that aorticdissection maymimic other pathology and should be consideredwhen appropriate so as to minimize the possibility of delays.

, SADDLE PULMONARY EMBOLISM: IS IT AS BADAS IT LOOKS? A COMMUNITY HOSPITAL EXPERI-ENCE Sardi A, Gluskin K, Guttentag A, et al. Crit Care Med2011;39:2413–8.

The outcomes and clinical presentation for saddle pulmo-nary embolism (SPE) vary widely, and there is debate for theuse of thrombolytics or catheter thrombectomy based on rightheart dysfunction, measures seen on computed tomography an-giography (CTA) or cardiac enzyme elevation. In this study, tworadiologists retrospectively reviewed and evaluated for clot bur-den (CB) all CTAs coded for pulmonary embolism (PE) from allpatients at a single center from 2004 to 2009. All patient chartswere reviewed for echocardiography, treatments, and outcomes.SPE was found in 37 of 680 patients (5.4%), with a median ageof 60 years, of whom 41% were male and 83.7% were African-American. Of the 37, the most common comorbidities were un-derlying neurologic disease, recent surgery, smoking (all 24%),and malignancy (22%). Echocardiography was performed in 27patients (73%). Right heart enlargement and dysfunction oc-curred in 78%, and elevated pulmonary artery systolic pressurein 67%. The Qanadi scoring system for clot burden and pulmo-nary artery occlusion defines complete proximal obstructionwith a CB of 40 points; CTA demonstrated a high median scoreof 31 points. Therewere 2 deaths (5.4%), with CBs of 30 and 31,but the small number of deaths made it impossible to determinewhich characteristics were associated with mortality. The me-dian right-ventricle-to-left-ventricle diameter ratio was 1.39,and in those given thrombolytics it was 1.86 (p = 0.13), andthe median CB of those who received thrombolytics was 34,compared to 31. Inferior vena cava filters were placed in 46%.Unfractionated heparin was administered in 87%, low-molecu-lar-weight heparin in 11%, thrombolytics in 11%, and surgicalthrombectomy in 3%. Median length of hospital stay was 9days. Of the 4 patients who received thrombolytics, majorbleeds occurred in 2, one of which died of multi-organ failureon hospital day 13.

[Douglas Melzer, MD

Denver Health Medical Center, Denver, CO]

Comments: This small retrospective study demonstrated thatthe incidence of saddle pulmonary embolism was very low andthat when it did occur, it was almost always amenable to stan-dard therapy. This raises the question of when thrombolysis ormore invasive thrombectomy is really needed, especiallywhen 1 of the 2 patients receiving the former died in this cohort.It may be that SPE is not as life-threatening an entity as previ-ously believed. However, larger studies would have to be doneto verify this.